Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- RNVA +16.6%, (discloses an FY17 outlook; expects to begin generating sales from the clinical research organization relationship in the first half of 2017; discloses on Dec 29 co filed a Certificate of Designation with the Secretary of State of Delaware to authorize the issuance of up to 1.75 mln shares of Series F convertible preferred stock)
- GPS +8.2%, (December comps of +3% vs -5% year ago and -1% (BR +5%, ON -2%) last month; now expect full-year EPS to be modestly above high end of previous guidance range)
- HELE +4.2%, AEHR +3.5%, MNTA +3.5%, FC +3%, PSMT +0.7%
M&A news:
- OGXI +48.5% (will acquire privately held Achieve Life Science in an all-stock transaction; co will be renamed 'Achieve Life Sciences' following completion of merger),
Other news:
- QTNT +18.7% (Quotient Limited reports positive MosaiQ results from performance evaluation study for blood grouping)
- STML +16.7% (announces positive FDA meeting and agreement on expedited pathway to full approval of SL-401 in first-line BPDCN )
- MDCO +7.7% (attributed to Amgen / Sanofi cholesterol drug injunction decision)
- IONS +7.1% (signs collaboration deal with Novartis (NVS); provides near-term payments of $225 mln plus potential license fees, milestone and royalty payments)
- CTIC +5.2% (continued strength)
- NBIX +5.1% (provides update on FDA advisory committee for Ingrezza for the treatment of tardive dyskinesia; FDA decided to cancel the Psychopharmacologic Drugs Advisory Committee meeting which was originally scheduled for Feb 16, 2017)
- AMGN +3.8% (following cholesterol drug Praluent ruling)
- MNTA +3.5% (enters into a research collaboration and worldwide license agreement w/ CSL to develop and commercialize Fc multimer proteins; co to receive $50 million upfront license fee and up to $550 million in potential milestone payments from CSL)
- ANW +3.3% (light volume- launches new service center in Germany that will serve all German Baltic Sea ports and Southern Scandinavian ports; will acquire OBAST's existing share capital)
- BOX +3% (higher in after hours following CEO appearance on CNBC -- discussed Facebook partnership)
- URRE +2.9% (light volume; closed the sale of its Churchrock and Crownpoint properties in New Mexico to Laramide Resources for consideration valued at $12.5 mln)
- ILMN +2.2% (announced that GRAIL has received indications of interest to invest approximately $1B for its Series B financing primarily from undisclosed private and strategic investors; ILMN is invested in GRAIL),
Analyst comments:
- ZFGN +4.5% (upgraded to Mkt Outperform from Mkt Perform at JMP Securities)
- EXPE +1.4% (upgraded to Buy from Hold at Stifel )
- MON +0.9% (upgraded to Outperform from Underperform at CLSA)